American Renal Associates (ARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 25,292 | 12,506 | -2,328 | 26,145 | 17,022 |
| Depreciation Amortization | 29,193 | 19,118 | 9,337 | 46,590 | 32,663 |
| Income taxes - deferred | 5,622 | 1,574 | 1,650 | 121 | 5,492 |
| Accounts receivable | 17,277 | 10,471 | 311 | -2,624 | -3,832 |
| Accounts payable and accrued liabilities | -7,214 | -3,415 | 7,714 | -9,543 | -1,028 |
| Other Working Capital | 104,721 | 114,227 | 3,452 | -39,405 | -21,279 |
| Other Operating Activity | -4,456 | -3,519 | -6,458 | 17,537 | 6,065 |
| Operating Cash Flow | $170,435 | $150,962 | $13,678 | $38,821 | $35,103 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 1,358 | -11,756 | -5,772 | -13,722 | -11,605 |
| Net Acquisitions | N/A | N/A | N/A | -6,590 | -6,590 |
| Investing Cash Flow | $1,358 | $-11,756 | $-5,772 | $-20,312 | $-18,195 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 60,018 | 45,989 | 41,606 | 78,299 | 73,387 |
| Debt Repayment | -75,158 | -50,081 | -12,137 | -54,069 | -40,983 |
| Common Stock Issued | 967 | 1,212 | 154 | 10 | 53 |
| Common Stock Repurchased | N/A | -430 | -427 | -368 | N/A |
| Dividend Paid | -12 | -11 | -5 | -50 | -44 |
| Other Financing Activity | -55,581 | -21,645 | -9,212 | -63,137 | -44,431 |
| Financing Cash Flow | $-69,766 | $-24,966 | $19,979 | $-39,315 | $-12,018 |
| Beginning Cash Position | 34,494 | 34,494 | 34,494 | 55,300 | 55,300 |
| End Cash Position | 136,521 | 148,734 | 62,379 | 34,494 | 60,190 |
| Net Cash Flow | $102,027 | $114,240 | $27,885 | $-20,806 | $4,890 |
| Free Cash Flow | |||||
| Operating Cash Flow | 170,435 | 150,962 | 13,678 | 38,821 | 35,103 |
| Capital Expenditure | -15,809 | -11,756 | -5,772 | -23,122 | -17,905 |
| Free Cash Flow | 154,626 | 139,206 | 7,906 | 15,699 | 17,198 |